IL1B and Decreased total leukocyte count: Trial terminated early due to lack of benefit No difference in incidence of MACE No difference in inflammatory markers (WBC count, CRP, IL-1β, IL-6) at 8 months Increased incidence of leukopenia, non-basal-cell skin cancer